|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
30 March 2015 |
|
Main ID: |
NCT01588171 |
|
Date of registration:
|
26/04/2012 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Comparison of 2 Low Molecular Weight Heparin as a Thromboprophylaxis Postpartum
|
|
Scientific title:
|
Bemiparin Versus Enoxaparin as Thromboprophylaxis Following Vaginal and Abdominal Deliveries: A Prospective Clinical Trial |
|
Date of first enrolment:
|
May 2012 |
|
Target sample size:
|
7020 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01588171 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Prevention
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Iraq
| | | | | | | |
|
Contacts
|
|
Name:
|
Mahabad S. Ali, High Diploma |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hawler ministry of Health, Directorate of Health |
|
|
Name:
|
Rojan K. Jawad, High Diploma |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hawler Medical University |
|
|
Name:
|
Shahla K. Alalaf, Ass.Prof |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hawler Medical University |
|
|
Name:
|
Namir G. Al Tawil, Professor |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hawler Medical University |
|
|
Name:
|
Parez R. Muhammad, High Diploma |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hawler Medical University |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Presence of risk factors for venous thromboembolism
- Any parity
- Mode of delivery:vaginal, Emergency and Elective Caesarean section
- No any contraindications for Heparin
Exclusion Criteria:
- Active antenatal or postpartum vaginal bleeding.
- Placenta previa
- Thrombocytopenia
- Sever renal or liver diseases
- Uncontrolled sever hypertension
- Any patient who is already on Heparin during pregnancy
Age minimum:
15 Years
Age maximum:
48 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Venous Thromboembolic Diseases
|
|
Intervention(s)
|
|
Drug: Bemiparin
|
|
Drug: Enoxaparin
|
|
Primary Outcome(s)
|
|
Venous thromboembolism
[Time Frame: 40 days after delivery]
|
|
Secondary Outcome(s)
|
|
adverse effects
[Time Frame: after receiving the injections and till 40 days]
|
|
Secondary ID(s)
|
|
Hawler Medical University
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|